Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension

Circulation

Volumn 106, Issue 18, 2002, Pages 2305-2308

  Rothermund, Lars ^a   Vetter, Roland ^a   Dieterich, Maike ^a   Kossmehl, Peter ^a   Gögebakan, Özlem ^a   Yagil, Chana ^a   Yagil, Yoram ^a   Kreutz, Reinhold ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Endothelin; Heart failure; Hypertension; Sodium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; DARUSENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN; ENDOTHELIN A RECEPTOR; PHOSPHOLAMBAN; SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SARCOPLASMIC RETICULUM; STRAIN DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; FIBROSIS; HEART VENTRICLES; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; ORGAN SIZE; PHENYLPROPIONATES; PYRIMIDINES; RATS; RATS, INBRED STRAINS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM CHLORIDE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037195118     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000038703.78148.54     Document Type: Article

References (16)

1. Schiffrin EL. State-of-the-Art lecture: Role of endothelin-I in hypertension. Hypertension. 1999;34:876-881.
2. Elijovich F, Laffer CL, Amador E, et al. Regulation of plasma endothelin by salt in salt-sensitive hypertension. Circulation. 2001;103:263-268.
3. Yagil C, Kami G, Rubattu S, et al. Development, genotype and phenotype of the newly inbred sabra hypertension prone (SBH/y) and resistant (SBN/y) rat model of salt sensitivity and resistance. J Hypertens. 1996;14:1175-1182.
4. Nakov R, Pfarr E, Eberle E, et al. Darusentan: An effective endothelin A receptor antagonist for the treatment of hypertension. Am J Hypertens. 2002:15:583-589.
5. 2- uptake. Circulation. 2000;102:1582-1588.
6. 2+ exchanger and SR Ca2+-ATPase in developing rat heart. Am J Physiol. 1998;275:H264-H273.
7. Yagil Y, Yagil C. Genetic basis of salt-susceptibility in the Sabra rat model of hypertension. Kidney Int. 1998;53:1493-1500.
8. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822-828.
9. de la Bastie D, Levitsky D, Rappaport L, et al. Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res. 1990;66:554-564.
10. Qi M, Shannon TR, Euler DE, et al. Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy. Am J Physiol. 1997;272:H2416-H2424.
11. Okayama H, Hamada M, Kawakami H, et al. Alterations in expression of sarcoplasmic reticulum gene in Dahl rats during the transition from compensatory myocardial hypertrophy to heart failure. J Hypertens. 1997;15:1767-1774.
12. Hasenfuss G, Reinecke H, Studer R, et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res. 1994;75:434-442.
13. Meyer M, Bluhm WF, He H, et al. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol. 1999;276:H779-H785.
14. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
15. Gallego MS, Ling BN. Regulation of amiloride-sensitive Na+ channels by endothelin-1 in distal nephron cells. Am J Physiol. 1996;271:F451-F460.
16. Exner DV, Dries DL, Domanski MJ, et al. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med. 2001;344:1351-1357.